"Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines. 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK). In this report, the data of China comes from NICPBP (National Institutes for Food and Drug Control)." Scope of the Report: This report focuses on the Pneumococcal Vaccine in Europe market, especially in Germany, UK, France, Russia, and Italy. This report categorizes the market based on manufacturers, countries, type and application. Market Segment by Manufacturers, this report covers Pfizer GSK MSD Sanofipasteur CDIBP Market Segment by Countries, covering Germany UK France Russia Italy Market Segment by Type, covers PPSV 23 PCV 7/13 PCV 10 Market Segment by Applications, can be divided into Child Adult There are 17 Chapters to deeply display the Europe Pneumococcal Vaccine market. Chapter 1, to describe Pneumococcal Vaccine Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Pneumococcal Vaccine, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers in Europe, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the Europe market by countries, covering Germany, UK, France, Italy and Russia, with sales, price, revenue and market share of Pneumococcal Vaccine, for each country, from 2012 to 2017; Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type and application, from 2012 to 2017; Chapter 7, 8, 9, 10 and 11, to analyze the key countries by manufacturers, Type and Application, covering Germany, UK, France, Italy and Russia, with sales, revenue and market share by manufacturers, types and applications; Chapter 12, Pneumococcal Vaccine market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022; Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc. Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers); Chapter 15, to describe Pneumococcal Vaccine sales channel, distributors, traders, dealers etc. Chapter 16 and 17, to describe Pneumococcal Vaccine Research Findings and Conclusion, Appendix, methodology and data source
Table of Contents 1 Market Overview 1.1 Pneumococcal Vaccine Introduction 1.2 Market Analysis by Type 1.2.1 PPSV 23 1.2.2 PCV 7/13 1.2.3 PCV 10 1.3 Market Analysis by Applications 1.3.1 Child 1.3.2 Adult 1.4 Market Analysis by Countries 1.4.1 Germany Status and Prospect (2012-2022) 1.4.2 France Status and Prospect